ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,146, issued on March 31, was assigned to NONA BIOSCIENCES (SUZHOU) Co. LTD. (Suzhou, China).
"CLDN18.2-targeting antibody, preparation method therefor, and use thereof" was invented by Ming-Jin Jheng (Suzhou, China), Wei Zhang (Suzhou, China) and Jieli Wang (Suzhou, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a CLDN18.2-targeting antibody or an antigen-binding fragment thereof, a preparation method therefor, and the use thereof. The antibody comprises a light chain variable region and/or a heavy chain variable region, and the heavy chain variable region comprises HCDR1, HCDR2 and HCDR3, and the light chain variable region comp...